Isabella Caligiuri

Via Franco Gallini 2
Aviano, 33081, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Peptide-Functionalized Gold Nanoparticles Targeting PD-L1: Design via a Molecular Dynamic Driven Approach and Further Experimental Validation.

Peptide-Functionalized Gold Nanoparticles Targeting PD-L1: Design via a Molecular Dynamic Driven Approach and Further Experimental Validation.

Journal: ACS applied bio materials

Published: May 26, 2026

Editorial Expression of Concern: Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1.

Editorial Expression of Concern: Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1.

Journal: Cell death and differentiation

Published: December 02, 2025

Synthesis of azulenyl-substituted gold(i)-carbene complexes and investigation of their anticancer activity.

Synthesis of azulenyl-substituted gold(i)-carbene complexes and investigation of their anticancer activity.

Journal: RSC advances

Published: September 16, 2025

Facile and green synthesis of [Pd(NHC)(η3-R-allyl)Cl] complexes and their anticancer activity.

Facile and green synthesis of [Pd(NHC)(η3-R-allyl)Cl] complexes and their anticancer activity.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: July 16, 2025

Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer.

Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer.

Journal: Cancer letters

Published: June 08, 2025

Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold.

Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold.

Journal: Bioorganic chemistry

Published: June 04, 2025

Influence of the charge of 1,3,5-triaza-7-phosphaadamantane-based ligands on the anticancer activity of organopalladium complexes.

Influence of the charge of 1,3,5-triaza-7-phosphaadamantane-based ligands on the anticancer activity of organopalladium complexes.

Journal: RSC advances

Published: March 26, 2025

Self-targeted nanosystem for enhanced chemodynamic cancer therapy.

Self-targeted nanosystem for enhanced chemodynamic cancer therapy.

Journal: Biomaterials science

Published: March 18, 2025

Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy.

Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: February 19, 2025

Unraveling the Specific Recognition Between PD-L1 and Engineered CLP002 Functionalized Gold Nanostructures: MD Simulation Studies.

Unraveling the Specific Recognition Between PD-L1 and Engineered CLP002 Functionalized Gold Nanostructures: MD Simulation Studies.

Journal: Molecules (Basel, Switzerland)

Published: February 14, 2025

Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responses.

Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responses.

Journal: Journal of advanced research

Published: October 18, 2024

Liposomal Formulations of Metallodrugs for Cancer Therapy.

Liposomal Formulations of Metallodrugs for Cancer Therapy.

Journal: International journal of molecular sciences

Published: July 28, 2024

Showing 1-12 of 79

Last Updated: 09/26/2026